Cargando…
Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions
Atherosclerosis is a chronic inflammatory disease with complex pathological processes. MicroRNA-33 (miR-33), a novel non-coding RNA that coexpresses with sterol regulatory element-binding proteins (SREBPs), affects macrophage actions to prevent atherosclerosis. Fibroblast growth factor 21 (FGF21) is...
Autores principales: | Guo, Yuan, Luo, Fei, Yi, Yuhong, Xu, Danyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134291/ https://www.ncbi.nlm.nih.gov/pubmed/27905947 http://dx.doi.org/10.1186/s12944-016-0381-6 |
Ejemplares similares
-
Metformin promotes cholesterol efflux in macrophages by up-regulating FGF21 expression: a novel anti-atherosclerotic mechanism
por: Luo, Fei, et al.
Publicado: (2016) -
Exosome-delivered microRNAs of “chromosome 19 microRNA cluster” as immunomodulators in pregnancy and tumorigenesis
por: Bullerdiek, Jörn, et al.
Publicado: (2012) -
Polymorphism studies on microRNA targetome of thalassemia
por: Galehdari, Hamid, et al.
Publicado: (2018) -
Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves’ ophthalmopathy
por: Li, Kaijun, et al.
Publicado: (2014) -
Computational study of ‘HUB’ microRNA in human cardiac diseases
por: Krishnan, Remya, et al.
Publicado: (2017)